Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126704661 | 12670466 | 1 | I | 20160817 | 20160822 | 20160822 | EXP | US-GLAXOSMITHKLINE-US2016GSK120001 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126704661 | 12670466 | 1 | PS | Omega-3-acid ethyl esters Capsule | OMEGA-3-ACID ETHYL ESTERS | 1 | U | 21654 | CAPSULE | ||||||||||
| 126704661 | 12670466 | 2 | SS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | UNK | U | 21654 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126704661 | 12670466 | 1 | Product used for unknown indication |
| 126704661 | 12670466 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126704661 | 12670466 | Adverse drug reaction | |
| 126704661 | 12670466 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126704661 | 12670466 | 2 | 2006 | 0 |